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INTRODUCTION
T-cell development depends on the correct expression of an
intricate transcription factor network and on signaling from the
environment. T cells develop from multipotent progenitors that
migrate from the bone marrow to the thymus, where they become
dependent upon Notch signaling for their development and
survival (Yang et al., 2010). At the early CD4– CD8– double
negative (DN) stages, pro-T cells retain lineage plasticity until the
DN2b stage where they become committed pre-T cells. The ETS
family transcription factor PU.1 (Sfpi1 – Mouse Genome
Informatics) is important during early T-cell development (Back
et al., 2005; Nutt et al., 2005), and is highly expressed initially but
repressed during commitment (Fig. 1A). This pattern must be
maintained for development to succeed. In early T-cell stages,
PU.1 drives expression of cytokine receptors such as Il7r and Flt3,
and of genes that are important for cell communication
(Turkistany and DeKoter, 2011). However, it is also required for
the development and function of other cell types, including
hematopoietic stem cells (Iwasaki et al., 2005), multipotent
progenitors (Wontakal et al., 2011), myeloid cells (Ghani et al.,
2011) and B cells (Houston et al., 2007). Forced overexpression of
PU.1 can divert early T cells to a myeloid lineage (Anderson et
al., 2002; Dionne et al., 2005; Lefebvre et al., 2005; Laiosa et al.,
2006b). However, in the context of T-cell development the
progenitors are normally protected from diversion, even while
expressing high levels of PU.1, by their exposure to Notch
signaling from the environment (Franco et al., 2006; Laiosa et al.,
2006b) (Fig. 1A).
Tracking the effects on several dozen genes has shown that the
interaction between PU.1 and Notch can have dichotomous effects
on early T-cell progenitors, with cells partitioning between those
that maintain a T-cell gene expression pattern and those that shift
towards a myeloid pattern (Dionne et al., 2005; Franco et al., 2006).
This suggests competition between two self-reinforcing network
states. However, the actual gene network underlying this choice has
been obscure.
Here, we explore the mechanisms that mediate the regulatory
competition between PU.1 and Notch signals, using primary mouse
fetal thymocytes and a clonal pro-T-cell line system to dissect the
regulatory impacts of PU.1 and Notch signaling. We show that
Notch signaling does not inactivate PU.1 protein but re-channels its
transcriptional effects. However, PU.1 and Notch signaling are
involved in a mutually inhibitory network, as PU.1 can repress
Notch targets. Our results further reveal two branches of the T-cell
gene network that collaborate against the PU.1-mediated diversion:
one involving basic helix-loop-helix E proteins in a tight positive-
feedback loop with Notch; and a separate branch for Gata3 and the
Gata3-activating factor Myb. We show that PU.1 undermines Gata3
expression, foreshadowing diversion in individual cells. The two T-
cell lineage protective pathways converge as Myb and Notch
signaling each enable Gata3 expression to be maintained in the face
of high levels of PU.1.
MATERIALS AND METHODS
Mice
C57BL/6-Bcl2tg mice [B6.Cg-Tg(BCL2)25Wehi/J] were housed under
specific pathogen-free conditions, bred and cared for by Caltech Animal
Facility staff. Embryonic day (E) 14.5 or 15.5 fetal thymocytes were used.
All animal work followed protocols approved by the Institutional Animal
Care and Use Committee.
Cell culture
Scid.adh.2C2 cells were cultured in RPMI1640 with 10% fetal bovine
serum (Sigma-Aldrich), sodium pyruvate, non-essential amino acids,
penicillin/streptomycin/glutamine (Gibco/Life Technologies/Invitrogen)
and 50 μM β-mercaptoethanol. Cells were incubated at 5% CO2 and 37°C.
For Notch signaling inhibition, InSolution γ-Secretase Inhibitor X (EMD
Millipore) were added at 0.5 μM.
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SUMMARY
Hematopoiesis is a classic system with which to study developmental potentials and to investigate gene regulatory networks that
control choices among alternate lineages. T-cell progenitors seeding the thymus retain several lineage potentials. The transcription
factor PU.1 is involved in the decision to become a T cell or a myeloid cell, and the developmental outcome of expressing PU.1 is
dependent on exposure to Notch signaling. PU.1-expressing T-cell progenitors without Notch signaling often adopt a myeloid
program, whereas those exposed to Notch signals remain in a T-lineage pathway. Here, we show that Notch signaling does not alter
PU.1 transcriptional activity by degradation/alteration of PU.1 protein. Instead, Notch signaling protects against the downregulation
of T-cell factors so that a T-cell transcriptional network is maintained. Using an early T-cell line, we describe two branches of this
network. The first involves inhibition of E-proteins by PU.1 and the resulting inhibition of Notch signaling target genes. Effects of E-
protein inhibition can be reversed by exposure to Notch signaling. The second network is dependent on the ability of PU.1 to inhibit
important T-cell transcription factor genes such as Myb, Tcf7 and Gata3 in the absence of Notch signaling. We show that maintenance
of Gata3 protein levels by Myb and Notch signaling is linked to the ability to retain T-cell identity in response to PU.1.
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Fetal thymocytes were cultured on OP9-Delta-like1 (OP9-DL1) or OP9-
control stroma in α-MEM with 20% fetal bovine serum,
penicillin/streptomycine/glutamine, 50 μM β-mercaptoethanol, 5 ng/ml Il7,
5 ng/ml Flt3 ligand (cytokines from Peprotech).
Cell staining, flow cytometry and sorting
FITC, PE, APC, APCe780, Pacific Blue and PerCPCy5.5-conjugated
antibodies from eBioscience or Cell Signaling (against CD25, CD44, CD45,
Mac1/CD11b, CD11c, Thy1, NGFR and human CD8) were used for cell
surface staining. Fc receptors were first blocked with 2.4G2. PU.1
intracellular staining using the BD cytofix/cytoperm kit (Becton Dickinson
Immunocytometry Systems) was carried out using PU.1 (9G7) rabbit mAb-
AlexaFluor 647 and rabbit mAb IgG (#2985, Cell Signaling) as an isotype
control. Gata3 intracellular staining using Foxp3 Staining Buffer Kit
(eBioscience) was carried out with mouse anti-Gata3-AlexaFluor 647 and
mouse IgG1 κ as an isotype control (BD Biosciences Pharmingen). Data
presented are representative of multiple independent experiments with n=2
(Fig. 1C; Fig. 7C,D) and n=3-5 (Fig. 1B; Fig. 3A,B; Fig. 4A; Fig. 5A; Fig.
6B,C; Fig. 7B).
Cells were sorted using BDIS FACS Aria IIu or iCyt Mission Technology
Reflections cell sorters and analyzed using FACSCalibur (BDIS) or
MACSQuant (Miltenyi Biotec) analyzers and FlowJo software (Tree Star).
RNA extraction and quantitative real-time RT-PCR
cDNA was prepared from total RNA using RNeasy extraction kits (Qiagen)
and reverse transcribed using random primers and SuperscriptIII
(Invitrogen).
Specific gene expression in cDNA samples was measured by qRT-PCR
(ABI Prism 7900HT) using SyberGreenER mix (Invitrogen). Results were
calculated (ΔCt method) and normalized to Actinb levels. For actual values
see supplementary material Table S1A,B (Fig. 2) and Table S2A-E (Figs 3-
7). Primers used for qRT-PCR were described previously (David-Fung et al.,
2009; Li et al., 2010; Yui et al., 2010), or are listed in supplementary
material Table S3.
Heatmap generation
Heatmaps were generated using a Matlab (MathWorks) script written by Dr
Hao Yuan Kueh (California Institute of Technology, Pasadena, CA, USA).
Briefly, values are log10-transformed averages of expression levels
determined by qRT-PCR from 2-4 independent experiments: n=2 or 3
(Fig. 2C,D), n=4 (Fig. 3C; Fig. 4B), n=2 (Fig. 5B; Fig. 6D; Fig. 7E). Levels
for each gene in different samples are presented relative to the level in the
control sample (empty vector transduced=1.0). The color scale ranges from
~10−2 to 102 times this reference value, as indicated. Ordering of genes was
by hierarchical clustering (median method, Matlab).
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Fig. 1. Continuous Notch signaling is not required to protect fetal thymocytes from diversion. Notch signaling can protect cells with high PU.1
protein levels. (A) PU.1 and Notch signaling interactions during early T-cell development. (B) E15.5 fetal thymocytes transduced with PU.1 and empty
vector were cultured in different Notch signaling conditions (a-d) for 3 days with Il7 and Flt3 ligand. The transduced cells were analyzed for the
expression of the T-cell marker Thy1 and the myeloid marker Mac1. (C) E15.5 thymocytes were transduced with PU.1 or an empty vector (a-c). The
percentage of Mac1+ cells in samples expressing high, intermediate and low levels of PU.1 protein were obtained using flow cytometry.
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Cloning/subcloning
Gfi1-, Id2-, Bambi- and Cebpa-coding sequences were purchased from
Genscript and subcloned into retroviral vectors: LZRS or MIGR1 with a
GFP marker, or derivatives with an NGFR marker (New England Biolabs
reagents). For retroviral packaging, Phoenix-Eco cells were transfected with
long-term puromycin selection for LZRS-based vectors, whereas 293T cells
were transiently co-transfected with pCL-Eco plasmid for MIGR1-based
vectors. Tcf7 in a retroviral vector with a Vex reporter and ICN1 and
dnMAML in MIGR1 were kind gifts from Avinash Bhandoola and Warren
Pear, respectively (University of Pennsylvania, Philadelphia, USA).
Gata3shRNA in the Banshee retroviral vector was made by Gabriela
Hernandez-Hoyos (California Institute of Technology, Pasadena, CA,
USA).
Retroviral infection
Non-tissue culture treated plates (Corning) were incubated with Retronectin
(Takara) at 40-50 ng/ml overnight at 4°C. Retronectin was removed and
viral supernatant added and spun at 2000 g for 2 hours at 32°C. Unbound
virus was removed and cells added in their preferred medium at 1×106
cells/ml, then incubated for 4 hours or overnight.
Western blots
Cell extracts in Laemmli sample buffer were boiled for SDS-PAGE.
Proteins were transferred to PVDF Immobilin (Millipore) and blots were
blocked with 5% milk in TBS-T (Tris-buffered saline, 0.5% Tween-20),
incubated with SP1 (sc-59) or PU.1 (sc-352) antibody (Santa Cruz
Biotechnology, 1:1000 dilution) and then with secondary antibody (1:2000).
Samples were then incubated with substrate (SuperSignal, Pierce) for film
detection.
RESULTS
Notch signaling protects against diversion at
early and late time points after PU.1
overexpression
In the early T-cell stages when PU.1 is active, it provides cells with
access to developmental alternatives and is therefore a risk to T-
lineage fidelity. We have shown previously that thymocytes can be
protected from PU.1-mediated lineage diversion if they receive
Notch signals (Franco et al., 2006), as they would in the normal
thymus in vivo. However, the mechanism through which Notch
signaling counteracts the activity of PU.1 has been obscure.
To investigate the critical time interval in which Notch signaling
affects thymocyte responses to PU.1, we forced fetal thymocytes to
express PU.1 by retroviral transduction and exposed them to differing
Notch signaling conditions for 3 days, using switch cultures based on
co-culture with OP9-DL1 or OP9-control stromal cells. BCL2-
transgenic (Bcl2tg) thymocytes were used to enhance recovery of
cells after regulatory perturbation (supplementary material Fig. S1)
(Franco et al., 2006; Taghon et al., 2007). OP9-control stroma
supports B cell, natural killer cell and myeloid development, but when
transfected to express the Notch ligand Delta-like1 (DL1), OP9-DL1
cells support T-cell development (Schmitt and Zúñiga-Pflücker,
2002). Thus, thymocytes were infected with empty vector or with
PU.1-expressing retrovirus during a 4-hour incubation, cultured with
OP9-DL1 or OP9-control stroma for 1 day, and then either returned
to the same Notch signaling condition or switched to the opposite
condition for 2 more days (Fig. 1B). Thy1, which is itself Notch
insensitive, was used to identify cells that had entered the T-cell
pathway (Taghon et al., 2007), as Mac1 (CD11b; encoded by Itgam)
marked entrance to the myeloid pathway (Dionne et al., 2005). As
these markers are normally mutually exclusive, activation of Mac1 on
Thy1+ cells identifies T-lineage cells beginning myeloid diversion.
Later, these become Mac1+ Thy1–.
On OP9-control stroma in the absence of Notch signals, the
empty vector-transduced thymocyte population was revealed to
include some cells with natural myeloid potential, but few were
Thy1+, i.e. derived from T-lineage precursors (Fig. 1Bb: 13% total
Mac1+ versus 2% Thy1+ Mac1+). Fetal thymocytes transduced with
PU.1 generated far more Mac1+ cells than thymocytes transduced
with empty vector under all conditions (Fig. 1B): if cultured in the
absence of Notch signals, most became Mac1+, over 50% derived
from Thy1+ cells. As expected, the samples cultured in the presence
of Notch signaling on OP9-DLl cells throughout the 3-day culture
contained a far smaller percentage of Thy1+Mac1+ diverted cells as
well as fewer Mac1+ cells overall than those cultured on OP9-
control. Notch signals restored for the last 2 days after an initial day
of deprivation also reduced diversion, as these samples mimicked
the conditions we had used previously (Franco et al., 2006).
Notably, however, samples that were initially cultured on OP9-DL1
for only 1 day and then shifted to OP9-control were also protected,
almost as strongly as in continuous presence of DL1 (Fig. 1Bc).
Thus, Notch signaling through the onset of PU.1 overexpression
could establish a regulatory state making Thy1+ fetal thymocytes
relatively resistant to diversion.
Pro-T cells with high levels of PU.1 protein are
able to resist Mac1 upregulation in the presence
of Notch signaling
A possible mechanism for protection of pro-T cells from PU.1-
mediated diversion could be to inactivate PU.1 protein. PU.1
phosphorylation can affect its DNA binding (Seshire et al., 2011) and
transactivation domain engagement (Hamdorf et al., 2011). Notch
signaling can regulate protein phosphorylation (Vo et al., 2011) and
trigger protein degradation by promoting ubiquitylation (Lim et al.,
2011). To test directly whether Notch-Delta signaling resulted in
changes in PU.1 protein levels, fetal thymocytes were infected with
PU.1 or empty vector and cultured on either OP9-DL1 or OP9-control
for 2 days, and then stained for both intracellular PU.1 and cell-
surface Mac1. The intermediate and high levels of PU.1 protein in
transduced cells matched the levels of endogenous PU.1 in those
control thymocytes that revealed natural myeloid potential when
Notch signals were removed (Fig. 1Ca, empty vector, OP9-control).
The distributions of PU.1 protein in PU.1-transduced cells were
not globally altered by the presence or absence of Notch signals.
However, the response to a given level of intracellular PU.1
depended strongly on Notch signaling, as cells made all-or-none
choices between remaining Mac1– and diverting to high Mac1+
states (Fig. 1Ca,c). High, intermediate and low levels of intracellular
PU.1 protein all drove over 90% of cells to become Mac1+ in the
absence of Notch ligand (Fig. 1Cb). In the presence of Notch ligand,
Mac1 could still be induced at the highest levels of PU.1 protein,
and Notch signaling did not affect the levels of Mac1 expressed
(Fig. 1Cc). However, the high, intermediate and low PU.1 level cells
each generated substantially lower Mac1+ percentages in the
presence of Notch signaling. Importantly, cells that now resisted
Mac1 upregulation (Fig. 1Cb,c) expressed the same levels of PU.1
protein that promoted Mac1 expression when Notch signals were
absent. Thus, Notch signaling can sharply raise the dose-dependent
threshold for PU.1 to induce expression of Mac1, without affecting
accumulation of PU.1 protein itself.
PU.1 protein is intact in the presence of Notch
signaling
Similarly, when PU.1 was introduced into a pro-T-cell-like cell line,
Scid.adh.2C2, western blotting measurements showed that Notch
signaling affected the PU.1 dose threshold for the cells to divert to a
Mac1+ state (supplementary material Fig. S2). However, qualitative
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PU.1 electrophoretic mobility patterns were the same in diverted and
diversion-resistant cells, whether Notch signaling was active or
inhibited, offering no evidence for differential phosphorylation or
ubiquitylation. This suggests that PU.1 itself remains biochemically
competent in the presence of Notch signaling.
Notch signaling effects on initial changes in gene
expression in fetal thymocyte responses to high-
level PU.1
Because even transient exposure to Notch signaling could protect
PU.1-overexpressing thymocytes from diversion, Notch signaling
might alter the earliest responses to PU.1. Previous studies had
shown that Notch signals protect important T-cell genes from
repression 40-48 hours after PU.1 transduction (Franco et al., 2006).
Those analyses were potentially skewed toward diversion, however,
because the cells were initially deprived of Notch signals during the
>16-hour transduction. In addition, survival effects could obscure
gene-specific regulation, for thymocytes naturally increase Notch-
dependence as they progress from DN2 to DN3, when many T-cell
genes are induced (Yui et al., 2010). Therefore, we infected fetal
thymocytes with PU.1 or empty vector for only 4 hours, then
cultured them with or without Notch signaling for 16 hours before
sorting for RNA analysis, separately isolating transduced DN2 and
DN3 cells (Fig. 2; supplementary material Table S1A,B).
The genes analyzed showed four different patterns of response
to PU.1 and Notch-DL1 interaction, as illustrated by representative
bar graphs of expression for individual genes (Fig. 2A,B) and
summary heatmaps of PU.1 effects on DN2 and DN3 cell gene
expression (Fig. 2C,D). The normal developmental expression
patterns of key genes are also shown (Fig. 2E). One group of genes
was upregulated efficiently by PU.1 overexpression, whether Notch
signaling was present or absent (e.g. Fig. 2A,C,D). This group
included the stem and progenitor cell-associated genes Lyl1, Bcl11a
and Hhex, and the myeloid gene Fes. The effectiveness of PU.1 was
partly constrained by the natural limits of the expression of these
genes from DN2 to DN3 (Zhang et al., 2012) (Fig. 2E): e.g. effects
on Hhex and Lmo2 were seen in DN2 cells but not significantly in
DN3 cells (supplementary material Table S1C). Only select genes,
e.g. Lmo2 (Fig. 2A) and Mac1 (Itgam), were inhibited from
responding to PU.1 by Notch-DL1 interaction. Thus, PU.1 can
indeed act positively on many target genes, even in the presence of
Notch signaling.
Genes specifically expressed in the T lineage showed three
patterns of response (Fig. 2B-D). Some were downregulated by
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PU.1 whether or not Notch signaling was present. These included
Ets1 and the crucial T-cell regulatory gene Tcf7, a gene that is
initially induced by Notch (Germar et al., 2011; Weber et al., 2011)
but is not acutely dependent on Notch signaling for its maintenance.
Another pattern was defined by Notch target genes [e.g. Deltex1,
Hes1, HEBalt (Tcf12) and Nrarp], which depended on Notch signals
even in control cells: e.g. Deltex1. A third group consisted of genes
that were downregulated by PU.1, but much more severely if Notch
signaling was absent. These included genes important for T-cell
development, such as Myb, Fog1 (Zfpm1) and Gfi1. However, in
general, the Notch target genes were also PU.1 inhibited, and
additively affected by Notch deprivation and PU.1 (Fig. 2B-D:
Nrarp, HEBalt and Hes1).
Though we anticipated Notch to influence PU.1 effects, these
results suggest that PU.1 in early T cells also antagonizes responses
to Notch. Thus, PU.1+ cells may demand higher-intensity Notch
signaling to maintain expression of directly and indirectly Notch-
regulated genes.
A clonal early T-cell line can be used to study
Notch signaling protection against diversion of
pro-T cells
The lasting protective effects of Notch signaling in early pro-T cells
and its impact on early responses to PU.1 overexpression imply that
these early affected genes may be involved in deciding between
protection and diversion in cells with high PU.1 expression. Testing
these genes for epistatic or synergistic effects by co-transfection
would be difficult in fetal thymocytes. Therefore, we used a
previously described early T-cell line (Dionne et al., 2005) devoid
of intrinsic myeloid potential, which is much more permissive for
co-transduction experiments.
Scid.adh.2C2 cells, DN3-like cells that do not express
endogenous PU.1, have previously been used to demonstrate the
all-or-none diversion response of early T-cells after PU.1
overexpression (Dionne et al., 2005). Scid.adh.2C2 cells were
cloned from a cell line, Scid.adh, which is derived from a
spontaneous pro-T cell tumor (Carleton et al., 1999), and show
spontaneous, ligand-independent Notch pathway activation. We
tested whether the Scid.adh.2C2 response to PU.1 was also subject
to Notch-dependent protection. Notch signaling in these cells was
inhibited by γ-secretase inhibitor (GSI), as shown by the
downregulation of the Notch-dependent marker, CD25 (Fig. 3A,
‘empty vector’, 0.5 μM GSI). Cells survived well with or without
Notch signaling. Scid.adh.2C2 cells transduced with PU.1
upregulated Mac1 in a fraction of the population, and the percentage
of cells becoming Mac1+ increased with the addition of GSI
(Fig. 3A). Interestingly, another Scid.adh subclone that was unable
to divert in response to PU.1 alone (6D4) (Dionne et al., 2005) also
showed strong diversion when Notch signaling was inhibited
(supplementary material Fig. S3). Thus, Notch signaling limits the
response to PU.1 in these Scid.adh-derived clonal cell lines as in
primary thymocytes.
Although many PU.1-overexpressing Scid.adh.2C2 cells
upregulated Mac1, a population of Mac1-CD25+ cells still remained.
CD25 is encoded by a Notch target gene, Il2ra (Maillard et al., 2006),
and expression levels of other Notch target genes correlate with CD25
levels (M.M.D.R., unpublished). Individual Scid.adh.2C2 cells that
remain Mac1 negative might simply express insufficient PU.1 to
divert, or they might resist because of higher Notch signaling,
suggested by their high CD25 expression. To distinguish these
possibilities, we transduced Scid.adh.2C2 cells with PU.1 for 2 days,
sorted the apparently diversion-resistant PU.1+Mac1–CD25+ cells,
then cultured them for 2 more days with or without GSI and assessed
whether they remained Mac1 negative (Fig. 3B). Some cells in the
vehicle control samples did upregulate Mac1 after 2 days, but the cells
cultured in GSI generated a much higher percentage of Mac1+ cells
(Fig. 3B). Thus, Scid.adh.2C2 cells expressing levels of PU.1 that are
barely adequate for diversion can be efficiently diverted when
endogenous Notch signaling is blocked.
Diversion depends on PU.1-mediated inhibition of
Notch signaling in Scid.adh.2C2 cells
Although inhibition of Notch signaling facilitated diversion, the
final molecular phenotype of the diverted cells was the same with
or without Notch inhibition, and the features of this response
largely matched those of fetal thymocytes. Fig. 3C and Table 1
(values in supplementary material Table S2A; Fig. S4A)
summarizes gene expression patterns in cells that were transduced
with PU.1 or empty vector and cultured for 2 days with GSI or
control vehicle, then sorted to separate Mac1+ diverted cells from
cells remaining Mac1–. A set of Notch-dependent target genes was
detectably inhibited by GSI, both in the absence of PU.1 and in
PU.1-transduced cells (Table 1). In addition, PU.1 turned on one
set of genes that was neither dependent on Notch signaling nor on
Notch inhibition (Table 1). These were activated in Mac1+ and
Mac1– PU.1-expressing cells alike, showing that PU.1 is active in
all these cellular contexts. However, the induction of Mac1 by
PU.1 heralded a global gene expression shift. Macrophage-
associated genes such as Csf1r and Mac1 (Itgam) were
upregulated by PU.1 selectively in the cells becoming Mac1+
(Table 1). As in fetal thymocytes, PU.1 also inhibited T-cell genes
(Table 1). Unlike activation, repression primarily occurred in
Mac1+ cells, not in cells remaining Mac1– (Table 1), implying that
these genes are repressed only when the regulatory threshold for
diversion has been crossed. Notably, cells becoming Mac1+ in
response to PU.1 alone maximally downregulated the Notch target
genes, with or without GSI (Table 1). Thus, forced PU.1
expression can initiate a mechanism that leads to severe Notch
pathway inhibition in Scid.adh.2C2 cells, and this event is tightly
correlated with diversion.
Dissection of PU.1-dependent gene expression
effects in the presence and absence of Notch
signaling
To dissect the mechanism of Notch pathway interaction with PU.1,
we used Scid.adh.2C2 cells for co-transduction experiments to
combine PU.1 with constitutively active Notch1 (ICN1) or the
dominant-negative inhibitor of Notch-dependent transcription,
dnMAML (Maillard et al., 2004). Doubly transduced cells were
sorted based on their co-expression of both viral vectors after 2 days.
When ICN1 was co-expressed with PU.1, most of the cells
remained CD25+ and did not upregulate Mac1. This protection
depended on Notch-dependent transcription, as the addition of
dnMAML with PU.1 not only extinguished CD25 expression but
also caused most of the cells to upregulate Mac1 (Fig. 4A).
However, PU.1 could still induce gene expression changes in
Scid.adh.2C2 cells, including expression of the dendritic-cell
marker CD11c, even in the presence of ICN1 (Fig. 4A).
The ability to manipulate Notch signaling independently of PU.1,
while maintaining viability, enabled us to ask how much of the
‘PU.1’ effect on T-cell gene expression depended on its Notch
inhibition effects (Fig. 4B). Doubly transduced cells (Fig. 4A) were
sorted for RNA analysis (fewer than 12% of PU.1+ ICN1+ cells were
Mac1+; over 70% of PU.1+ dnMAML+ cells were Mac1+). As
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expected, PU.1 with dnMAML mimicked the full range of the
diverted phenotype. However, separate regulatory components were
distinguished with dnMAML alone, and when PU.1 expression was
combined with ICN1 (Fig. 4B; supplementary material Table S2B;
Fig. S4B). Forced expression of ICN1 could protect classic Notch
target genes, even in the presence of PU.1 (supplementary material
Table S2B, ‘response group’ 5), and these genes could be
upregulated by ICN1 alone (supplementary material Table S2B,
group 2), implying an additive effect. However, three additional
relationships emerged.
First, ICN1 could not protect all T-cell genes from PU.1
(supplementary material Table S2B, group 6). Thus, PU.1 represses
these genes through a mechanism that depends on something
besides Notch inhibition. Second, expression of some PU.1-
dependent genes were actually enhanced by ICN1, implying distinct
gene-specific rules for interaction (supplementary material Table
S2B, group 4). Third, importantly, T-cell regulatory genes, including
Myb, Tcf7 and, to a lesser extent, Gata3 were only downregulated
by PU.1 when combined with loss of Notch signaling
(supplementary material Table S2B, group 7): they were minimally
affected by ICN1, dnMAML or PU.1 alone. dnMAML alone was
highly effective at blocking Notch target gene expression
(supplementary material Table S2B, group 1), and yet had
absolutely no effect on Myb, Tcf7, Gata3 or Fog1. However, in a
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Table 1. Gene responses to PU.1 forced expression and Notch signaling
Response group Genes
(1) Notch dependent Rag1, Hes5, Ptcra, Notch1, Lef1, Dtx1, Nrarp
(2) PU.1 activated Lyl1, Bcl11a, Bambi, Itgam, Zeb2, Egr2, Runx3, Pou6f1, Id2
(3) PU.1 activated only (more) in Mac1+ diverted cells Csf1r, Egr2, Id2 (Bambi, Itgam)
(4) Downregulated by PU.1 Ets1*, Aiolos*, Flt3*
(5) Downregulated by PU.1 only (more) in diverted cells Myb, Tcf7, Trib2, HEBalt, Zfpm1, Hes1, Il7ra, Tcfe2a, Bcl11b, Gfi1, Gata3, HEBcan,
Psen2, (Ets1), (Flt3)
(6) Downregulated in diverted cells and in Notch-inhibited cells Rag1, Hes5, Ptcra, Notch1, Lef1, Dtx1, Nrarp
Summary of results in Fig. 3C.
Genes in parentheses show a greater change in these conditions.
*Slight but reproducible effects.
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CD11c+ Mac1– intermediate stage leading to diversion, Myb, Tcf7
and Gata3 also remained less affected (supplementary material Fig.
S5). Thus, to complete diversion (Fig. 3C), PU.1 must shut off these
genes by another mechanism, beyond antagonism of Notch, even
though Notch signaling maintains the inputs that protect their
expression.
Id2 co-infection with PU.1 increases diversion to
Mac1+ cells via inhibition of the Notch pathway in
Scid.adh.2C2 cells
The data thus far indicate that diversion to a Mac1+ state is linked
with PU.1-dependent repression of at least two distinct groups of
T-cell genes. Of these, Notch-dependent target genes such as those
inhibited by dnMAML (supplementary material Table S2B, group
1) represent one component, but others such as Myb, Gata3, Gfi1
and Tcf7 represent a separate, possibly rate-limiting, component.
These genes encode among the most important transcription factors
known for T-cell development (Rothenberg et al., 2008) and may
themselves play a role in maintaining T-cell identity.
We reasoned that extinction of the T-cell program must occur
only when the T-cell gene(s) that resist(s) diversion was finally
turned off or neutralized. This resistance factor might be TCF1
(encoded by Tcf7), Myb, Gfi1 or Gata3, but it might also be basic
helix-loop-helix E protein (E2A, HEB, TCF12) activity, which
reportedly controls both T-cell differentiation genes such as Rag1
and other T-cell regulatory genes (Ikawa et al., 2006; Schwartz et al.,
2006). Indeed, PU.1 could neutralize E proteins: in Mac1+ diverted
cells, the E protein antagonist Id2 is upregulated, and this
upregulation is blocked by Notch signaling. Although this response
is weak on its own, PU.1 overexpression also reduces expression
of the E proteins E2A, HEB (canonical) and HEBalt in
Scid.adh.2C2 cells and fetal thymocytes alike (Franco et al., 2006).
To test whether E protein activity could set the threshold for
diversion in response to PU.1, we co-expressed Id2 with PU.1 in
Scid.adh.2C2 cells. In fact, Id2 and PU.1 together reproducibly
increased the percentage of cells becoming Mac1+ when compared
with PU.1 alone (Fig. 5A). This distinguished Id2 from two other
regulators that we tested as alternative candidates for collaborators
with PU.1. Both the well-known myeloid factor C/EBPα and the
PU.1-induced factor BAMBI failed to increase the percentage of
PU.1-transduced Scid.adh.2C2 cells becoming Mac1+, although
C/EBPα did reduce CD25 expression (supplementary material Fig.
S6A and data not shown). Id2 overexpression alone also decreased
CD25 levels, although it did not upregulate Mac1. This suggested
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that the Id2 effect might involve inhibition of Notch signaling. E
proteins have been shown to be rate-limiting positive regulators of
Notch1 (Yashiro-Ohtani et al., 2009), as well as positive contributors
to the expression of some Notch target genes (Ikawa et al., 2006)
such as Ptcra.
Gene expression analysis confirmed that Notch target genes are
downregulated maximally in samples with Id2 alone, as well as in
samples co-expressing PU.1 and Id2 (Fig. 5B; supplementary
material Table S2C, group 1). If Id2 overexpression affects the same
pathway as Notch inhibition, then forced Notch signaling in PU.1
and Id2 co-expressing samples might be epistatic to Id2. In a triple-
transduction experiment, Scid.adh.2C2 cells were infected with
PU.1, Id2 and ICN1. Cell surface staining of these cells after 2 days
showed that the effect of Id2 to enhance diversion to Mac1+ cells
was indeed canceled out when Notch signaling was enforced by the
addition of ICN1 (Fig. 5A, bottom). Thus, E protein antagonism
does play a role in diversion, and induction of Id2 and repression of
E2A and HEB probably provide one part of the mechanism through
which PU.1 inhibits Notch activation in a positive feedback to
promote a myeloid fate.
However, Id2 alone had minimal effect on Gfi1, Myb or Tcf7
expression (supplementary material Table S2C, groups 4 and 5).
Furthermore, as reported in earlier E2A knockdown studies (Xu and
Kee, 2007), we detected an upregulation of Gata3 with Id2 alone
(supplementary material Table S2C, group 2), an effect reversed
when PU.1 was present and quite different from the phenotype of
diverted cells. Therefore, the mechanism through which these T-
lineage regulatory target genes are inhibited by PU.1 to complete
diversion is not simply by blocking E protein activity, any more
than it is simply by blocking Notch activity.
Myb protects against PU.1-driven diversion
Myb and Tcf7 were consistently downregulated in response to PU.1
during diversion, and were prominent candidates as diversion
‘barriers’ because the cells do not turn on Mac1 until these two
genes are downregulated (Fig. 3C; supplementary material Fig. S3).
Myb is already expressed strongly during the first stage of T-cell
development (DN1), increasing slightly in the DN2 and DN3 stages
(Tydell et al., 2007) (Fig. 2E). To test whether forced expression of
Myb could block the ability of PU.1 to upregulate Mac1, we infected
Scid.adh.2C2 cells with retroviral Myb for 24 hours, then
superinfected them with PU.1 and cultured the cells for an
additional 48 hours (Fig. 6A). Despite increasing Myb less than
threefold over the level normally expressed in Scid.adh.2C2 cells,
co-transduction of Myb with PU.1 modestly but reproducibly
decreased the percentage of Mac1+ cells (Fig. 6B,C).
Gene expression analysis (Fig. 6D; supplementary material Table
S2D) showed that Myb did not inhibit PU.1 from upregulating
targets such as Bcl11a. Importantly, protection by Myb did not seem
to be mediated primarily through Notch signaling either, as Myb
did not prevent PU.1 repression of Notch target genes
(supplementary material Table S2D3). However, Gfi1, Tcf7, Gata3
and HEBalt were expressed at higher levels in cells with Myb and
PU.1 compared with those with PU.1 alone (supplementary material
Table S2D, groups 2 and 4). This group of protected genes was
tested in turn for protection against PU.1-mediated diversion, but
they did not perform as well as Myb. TCF1 (Tcf7) was a high
priority candidate; however, the percentage of cells co-expressing
TCF1 and PU.1 that were Mac1+ was the same as the percentage of
cells expressing PU.1 and an empty vector (supplementary material
Fig. S6B), and Tcf7-shRNA did not increase diversion (not shown).
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Co-expression of Gfi1 or HEBalt with PU.1 also did not block
induction of Mac1 (supplementary material Fig. S6C,D). In fact,
Gfi1 actually exacerbated the diversion response in the
Scid.adh.2C2 cells, and in fetal thymocytes, when co-expressed
with PU.1 (supplementary material Fig. S6C and data not shown).
Thus, although incomplete, the protective effect of Myb against
diversion was specific, implicating Myb and Notch signaling as
separate control points for resistance to diversion.
A specific effect of PU.1 on Gata3 protein: Myb
protects Gata3 protein levels
The gene that was most affected by Myb overexpression, one that
Myb rendered most resistant to PU.1, was Gata3. Indeed, Myb-
transduced cells expressed higher levels of Gata3 RNA than
controls with or without PU.1, raising the issue of whether Gata3
could help to resist diversion. Gata3 is essential and rate limiting
for T-lineage development and is specifically downregulated in
Mac1+ cells (Fig. 3C). It was lower priority to test for control of
pro-T-cell lineage fidelity only because the magnitudes of PU.1 and
Notch effects on Gata3 RNA were small. To test for Gata3 effects
more sensitively at the single-cell level, we performed intracellular
staining of the Gata3 protein in Scid.adh.2C2 cells with and without
overexpressed PU.1 (Fig. 6E). In fact, PU.1 overexpression
markedly downregulated Gata3 protein levels in one subset of the
transduced cells, even though it slightly upregulated Gata3 protein,
relative to controls, in another subset. This split had the same all-or-
none quality as the diversion response itself. Gata3 downregulation
was seen at a much greater frequency in cells expressing high levels
of PU.1 (Fig. 6E), in which Gata3 levels were 5- to 10-fold reduced.
Those cells that downregulated Gata3 protein were also the ones
that upregulated Mac1 (Fig. 6F).
Myb may positively regulate Gata3 in later T-cell development
(Maurice et al., 2007; Gimferrer et al., 2011). To test whether Myb
could also maintain Gata3 despite PU.1 overexpression, we compared
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Gata3 protein levels in Scid.adh.2C2 cells co-expressing PU.1 and
Myb with Gata3 in cells co-expressing PU.1 and an empty vector
(Fig. 6G). Cells co-expressing PU.1 with an empty vector showed
lowered Gata3 protein levels, but Gata3 was rescued to normal levels
in cells co-expressing PU.1 and Myb (Fig. 6G). Guaranteed
expression of Myb thus seems to protect Scid.adh.2C2 cells from the
PU.1-driven mechanism that downregulates Gata3 protein.
Gata3 as a gatekeeper: Gata3 knockdown in PU.1-
expressing cells enhances Mac1 upregulation
To investigate whether Gata3 downregulation was simply a marker
or actually caused differences in the ability of PU.1 to divert the
cells, we used shRNA to reduce Gata3 expression in PU.1-
transduced cells and measured the impact on diversion.
Scid.adh.2C2 cells were first infected with a construct expressing a
short hairpin RNA against Gata3 (Hernández-Hoyos and Alberola-
Ila, 2005); then after 24 hours the cells were infected with a PU.1-
expressing vector and cultured for 48 hours more (Fig. 7) before
analysis. The Gata3-shRNA alone knocked down Gata3 protein to
levels that were comparable with the lowest Gata3 protein levels in
PU.1-expressing cells (Fig. 7A). Unexpectedly, the Scid.adh.2C2
cells co-expressing Gata3 shRNA together with PU.1 had even
lower levels of Gata3 protein, some with 20-fold reduction
compared with unperturbed cells. This Gata3 reduction made PU.1-
expressing cells more susceptible to diversion. As shown in Fig. 7B,
the fraction of cells remaining Mac1– CD11c– was halved, while
increased percentages of cells acquired these myeloid markers.
Reduced Gata3 protein by itself had little effect on gene
expression in the Scid.adh.2C2 cells, but the combination of PU.1
expression and Gata3 knockdown had a powerful effect on gene
expression (Fig. 7E; supplementary material Table S2E). Gata3
knockdown did not generally cause further upregulation of genes
induced by PU.1, and it did not exacerbate PU.1-mediated
repression of several Notch targets (supplementary material Table
S2E, group 3). However, we found that the multiple T-cell genes
downregulated by PU.1 were further downregulated in cells with
PU.1 and lowered Gata3 (supplementary material Table S2E, group
4). Notch1 and Notch3 themselves were affected. Loss of Gata3 thus
sensitizes cells to the effects of PU.1, with a potency comparable to
Notch inhibition.
Notch and Gata3 pathway interlinkage: Notch
signaling makes Gata3 resistant to PU.1
These results imply that Gata3 downregulation can complement the
inhibition of Notch responses by PU.1 and make cells susceptible to
diversion. However, our earlier results indicate that direct
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manipulations of Notch signaling were also sufficient to regulate
PU.1-driven diversion, despite little detectable effect of Notch
inhibition on Gata3 RNA. In fact, dnMAML alone could slightly
elevate Gata3 RNA (Fig. 4B). To revisit whether there is any
convergence between these two regulatory mechanisms for
protecting T-cell identity, we tested whether manipulations of Notch
signaling in the context of PU.1 activity might have clearer effects
on Gata3 protein.
By themselves, transduction with dnMAML or ICN1 had
virtually no effect on Gata3 protein levels in Scid.adh.2C2 cells
(supplementary material Fig. S7). However, when PU.1
transduction was combined with dnMAML or ICN1, the effect on
Gata3 was dramatic (Fig. 7C). Cells co-expressing PU.1  and ICN1
uniformly expressed Gata3 at the highest level. By contrast, cells co-
expressing PU.1 and dnMAML shifted almost completely to the
low level of Gata3, normally seen only in cells with the highest
expression of PU.1. Thus, Notch signaling affects not only Notch
target gene expression but also the mechanism for Gata3
stabilization, with later impact on Gata3 targets.
Kinetically, the impact of Notch inhibition on Gata3 levels
could precede appearance of the diverted phenotype (Fig. 7D).
Mac1 expression is not evident on PU.1-transduced Scid.adh.2C2
cells until 48 hours (Fig. 7D, right panel). However, the
combination of PU.1 and dnMAML began to downregulate Gata3
protein in the whole population of transduced Scid.adh.2C2 cells
by 24 hours, falling lower by 48 hours. Thus, any decrease in
Notch signaling undermined the resistance of Gata3 in the cells
to inhibition by PU.1, precipitating the positive-feedback cascade
that eventually silences genes dependent on Gata3 and Notch
signaling alike.
DISCUSSION
T-lineage specification of blood-cell precursors is promoted by
Notch interaction, with Delta expressed in the thymic micro-
environment. However, throughout multiple cell cycles in this
environment, the differentiating precursors continue to express
transcription factors such as PU.1 that are associated with
multipotentiality. Their access to other fates is revealed if removed
from the thymus. How does the thymus predictably manage to
impose a T-cell fate on virtually all these cells, despite their intrinsic
delay of commitment? Our results reveal the architecture of a
regulatory gene network switch circuit through which
environmental Notch signaling interacts with PU.1 to determine T-
cell, myeloid or progenitor-cell status (Fig. 8).
Two branches of this network are positively regulated by PU.1.
One involves upregulation of myeloid genes such as Itgam and
Csf1r, whereas another involves expression of stem-cell or
progenitor-cell genes such as Bcl11a, Lyl1 and possibly also Bambi.
Environmental Notch signaling blocks activation of Itgam and
Csf1r, but not PU.1-dependent activation generally. Concomitantly,
there are two network branches through which PU.1 can negatively
regulate the T-cell differentiation program. Extinction of T-lineage
regulatory gene expression is most tightly correlated with a switch
to myeloid fate. One branch involves the ability of PU.1 to attenuate
transcriptional responses to Notch signaling: PU.1 raises the
threshold of Notch signaling needed for expression of Notch target
genes. This occurs in part through inhibition of an E protein –
Notch-positive feedback circuit. In parallel, however, we show that
PU.1 also antagonizes expression of a second set of T-cell regulatory
genes, including Myb and its activation target Gata3. These seem
crucial for sustaining Gfi1, Zfpm1 (Fog1) and Tcf7 expression in the
presence of PU.1. All these genes can also be protected against PU.1
by Notch signals, but are not otherwise Notch dependent, implying
that the protective effect of Notch on this gene set is indirect, e.g. via
maintenance of Gata3. Myeloid-lymphoid lineage choice is thus a
bifurcation between opposing feed-forward network circuits, one
dominated by PU.1, and the other by Notch signals that protect both
Notch-E protein targets and Myb-Gata3 targets.
Our results suggest that the balance may be tipped from resistance
to diversion by initial weakening of either protective mechanism in
PU.1-expressing cells. Reduction either of Gata3 or of Notch
signaling can sensitize the cells to diversion, and Notch signaling
not only protects Gata3 but also protects its positive regulator, Myb,
from inhibition by PU.1. However, it is notable that when PU.1 and
Notch signals ‘balance’, T-cell regulatory gene expression can be
maintained, along with expression of specific progenitor-associated
PU.1 target genes. This is exactly the situation in early T-cell
precursors before lineage commitment (Fig. 1A). Our results with
Bcl11a, Lyl1 and possibly also Hhex and Bambi regulation, all of
which are naturally expressed in early thymocytes, thus open the
way for PU.1 to play a stage-specific positive role for early T cells.
Our results are drawn from both primary fetal thymocytes and a
DN3-like clonal cell line, and the relationships are similar if not
completely identical. Scid.adh.2C2 cells do not perfectly match the
gene expression states of the primary cells, and as magnitudes of
specific gene expression responses to PU.1 change with normal
developmental progression, they also differ between the cell line
and the primary cells. These probably reflect differences in basal
Notch transduction machinery, E protein activity and Gata3
expression between these cell types (data not shown). Tcf7 is less
protected by Notch signaling in the primary cells than in
Scid.adh.2C2 cells, whereas genes such as Ptcra are more protected.
However, these are not the PU.1 repression targets that appear to
set the threshold against diversion. Instead, the key components of
the network core architecture shown in Fig. 8 are consistent with
results in both types of cells.
PU.1 opposition to Gata3 recalls the PU.1:GATA1 opposition that
underlies erythroid/myeloid fate determination, which is based in
part on protein-protein interaction (reviewed by Cantor and Orkin,
2002; Laiosa et al., 2006a). Here, Gata3 appears to be important for
Zfpm1 maintenance against PU.1, like GATA1 in erythroid
development. ChIP-seq analysis shows that Zfpm1, Gfi1, Myb and
Tcf7 are all linked with Gata3 binding sites in early T cells (Zhang
et al., 2012) (Bambi, Bcl11a, Itgam and Id2 are not), suggesting that
high PU.1 may primarily inhibit these T-cell genes by blocking
positive Gata3 inputs. However, Gata3-PU.1 antagonism itself is
more conditional. Although PU.1 reduces Gata3 protein when
Notch signaling is inhibited, PU.1 slightly upregulates Gata3 when
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Notch signals are active. PU.1 binds multiple sites around Gata3 in
early T cells (Zhang et al., 2012), potentially contributing to both
effects. PU.1 can be repressed by high-level Gata3 (Taghon et al.,
2007), but the genomic sites through which GATA1 silences PU.1
expression (Chou et al., 2009) are not bound by Gata3 in early T
cells (Zhang et al., 2012). Furthermore, although reduced Gata3
makes cells more diversion sensitive, increased Gata3 cannot bypass
the need for Notch signaling to make cells diversion-resistant (data
not shown). This suggests that PU.1-Gata3 relationships are
probably asymmetric.
The relationship between PU.1 and Notch signaling provides a
discrete, micro-environmental threshold setter for lymphoid
precursor fate determination. In normal thymocytes though not in
Scid.adh.2C2 cells, the signals actually received depend on
environmental density of Notch ligands. Within the pro-T cells,
signaling not only requires E proteins to maintain Notch1
expression but also a positive-feedback loop with E protein activity,
as expression of both Id2 and Id3 E protein antagonists increases
when Notch signaling is reduced. The molecular mechanism
through which PU.1 inhibits Notch-dependent transcription still
requires more investigation. However, our results show that the
expression of PU.1 in the earliest T-cell precursors itself becomes a
sensor that determines what level of Notch signal from the
environment will suffice to promote entry and forward progression
along the T-cell pathway.
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